000 | 01714 a2200493 4500 | ||
---|---|---|---|
005 | 20250513170534.0 | ||
264 | 0 | _c19990420 | |
008 | 199904s 0 0 eng d | ||
022 | _a0301-0430 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRahman, M M | |
245 | 0 | 0 |
_aRenal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine. _h[electronic resource] |
260 |
_bClinical nephrology _cFeb 1999 |
||
300 |
_a98-107 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xpharmacology |
650 | 0 | 4 |
_aCatalase _xpharmacology |
650 | 0 | 4 |
_aCyclic GMP _xurine |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 |
_aLipoproteins, LDL _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitrates _xurine |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aNitrites _xurine |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aRenal Artery _xphysiology |
650 | 0 | 4 |
_aSuperoxide Dismutase _xpharmacology |
650 | 0 | 4 | _aVasoconstriction |
650 | 0 | 4 |
_aomega-N-Methylarginine _xpharmacology |
700 | 1 | _aVarghese, Z | |
700 | 1 | _aFuller, B J | |
700 | 1 | _aMoorhead, J F | |
773 | 0 |
_tClinical nephrology _gvol. 51 _gno. 2 _gp. 98-107 |
|
999 |
_c10029660 _d10029660 |